Article
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling
2 Feb 2015
Abstract excerpt
Recombinant adenoviral vectors (rAds) are lead vaccine candidates for protection against a variety of pathogens, including Ebola, HIV, tuberculosis, and malaria, due to their ability to potently induce T cell immunity in humans. However, the ability to induce protective cellular immunity varies among rAds. Here, we assessed the mechanisms that control the potency of CD8 T cell responses in murine models following...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
